Safety and pharmacokinetics of GNbAC1, a humanised monoclonal antibody against the multiple sclerosis associated retrovirus envelope protein in patients with multiple sclerosis

被引：0

作者：

Derfuss, T. ^{[1
]}

Curtin, F. ^{[2
]}

Guebelin, C. ^{[1
]}

Bridel, C. ^{[3
]}

Rasenack, M. ^{[1
]}

Matthey, A. ^{[3
]}

Du Pasquier, R. ^{[4
]}

Schluep, M. ^{[4
]}

Desmeules, J. ^{[3
]}

Porchet, H. ^{[2
]}

Lang, A. B. ^{[2
]}

Perron, H. ^{[2
]}

Hartung, H. -P. ^{[5
]}

Kappos, L. ^{[1
]}

Lalive, P. ^{[3
]}

机构：

[1] Univ Basel Hosp, CH-4031 Basel, Switzerland

[2] GeNeuro SA, Geneva, Switzerland

[3] Univ Hosp Geneva, Geneva, Switzerland

[4] Univ Lausanne Hosp, Lausanne, Switzerland

[5] Univ Dusseldorf, Dusseldorf, Germany

来源：

MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：237 / 237

页数：1

共 50 条

[1] Safety and Pharmacokinetics of GNbAC1, a Humanised Monoclonal Antibody Against the Multiple Sclerosis Retrovirus Envelope Protein in Patients with Multiple Sclerosis
Derfuss, Tobias
LaLive, Patrice
Guebelin, Claudia
Rasenak, Maria
Kappos, Ludwig
Desmeules, Jules
Lang, Alois
Porchet, Herve
Perron, Herve
Curtin, Francois
NEUROLOGY, 2013, 80
[2] Safety and pharmacokinetics of GNbAC1, a humanised monoclonal antibody against the multiple sclerosis retrovirus envelope protein
Curtin, F.
Lang, A. B.
Perron, H.
Derfuss, T.
Lalive, P.
Kappos, L.
Hartung, H. -P.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 241 - 242
[3] A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients
Derfuss, Tobias
Curtin, Francois
Guebelin, Claudia
Bridel, Claire
Rasenack, Maria
Matthey, Alain
Du Pasquier, Renaud
Schluep, Myriam
Desmeules, Jules
Lang, Alois B.
Perron, Herve
Faucard, Raphael
Porchet, Herve
Hartung, Hans-Peter
Kappos, Ludwig
Lalive, Patrice H.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (07) : 885 - 893
[4] GNbAC1, a monoclonal antibody against the MSRV envelope protein, pharmacodynamic responses in patients with multiple sclerosis
Curtin, F.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 108 - 109
[5] Pharmacokinetic and safety study of GNbAC1, a humanized monoclonal antibody for multiple sclerosis
Porchet, H.
Lang, A.
Curtin, F.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 404 - 404
[6] GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis-Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study
Curtin, Francois
Lang, Alois B.
Perron, Herve
Laumonier, Marion
Vidal, Virginie
Porchet, Herve C.
Hartung, Hans-Peter
CLINICAL THERAPEUTICS, 2012, 34 (12) : 2268 - 2278
[7] A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up
Derfuss, Tobias
Curtin, Francois
Guebelin, Claudia
Bridel, Claire
Rasenack, Maria
Matthey, Alain
Du Pasquier, Renaud
Schluep, Myriam
Desmeules, Jules
Lang, Alois B.
Perron, Herve
Faucard, Raphael
Porchet, Herve
Hartung, Hans-Peter
Kappos, Ludwig
Lalive, Patrice H.
JOURNAL OF NEUROIMMUNOLOGY, 2015, 285 : 68 - 70
[8] Immunomonitoring of a phase II study testing the monoclonal antibody GNbAC1 in multiple sclerosis patients
Zimmermann, M.
Sanderson, N.
Rasenack, M.
Lalive, P.
Curtin, F.
Lang, A.
Kappos, L.
Derfuss, T.
MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 465 - 465
[9] The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
Diebold, Martin
Derfuss, Tobias
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
[10] High Dose Clinical Pharmacology Study of GNBAC1, a Humanized Monoclonal Antibody for Multiple Sclerosis
Curtin, Francois
Porchet, Herve
Lang, Alois
NEUROLOGY, 2016, 86

← 1 2 3 4 5 →